Moreover, studies have suggested that PRMT5 could be a potential target for developing anti-cancer therapies [18, 19], as inhibiting its activity has been shown to inhibit the growth of cancer cells and reduce tumor size. The gene discussed is PRMT5; the disease is cancer.